PT Sarana Meditama Metropolitan Tbk

Jakarta Stock Exchange SAME.JK

PT Sarana Meditama Metropolitan Tbk Operating Income for the year ending December 31, 2023: USD 3.08 M

PT Sarana Meditama Metropolitan Tbk Operating Income is USD 3.08 M for the year ending December 31, 2023, a -22.76% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

PT Sarana Meditama Metropolitan Tbk Operating Income for the year ending December 31, 2022 was USD 3.98 M, a -67.78% change year over year.
PT Sarana Meditama Metropolitan Tbk Operating Income for the year ending December 31, 2021 was USD 12.36 M, a 1,943.00% change year over year.
PT Sarana Meditama Metropolitan Tbk Operating Income for the year ending December 31, 2020 was USD 605.03 K, a 55.31% change year over year.
PT Sarana Meditama Metropolitan Tbk Operating Income for the year ending December 31, 2019 was USD 389.57 K, a -96.79% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Jakarta Stock Exchange: SAME.JK

PT Sarana Meditama Metropolitan Tbk

CEO	Mr. Jusup Halimi
IPO Date	Jan. 25, 2013
Location	Indonesia
Headquarters	Jalan Pulomas Barat VI No. 20
Employees	2,761
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

Key trends

Past 5 years